Sign in
4

Changes in Ownership

Cullinan Therapeutics, Inc. Filed Acc 0000950170-24-140856

President and CEO sold 8,400 shares at $11.87 ($99,708)

From the SEC's structured data for this filing

Trades in this filing

AHMED NADIM · President and CEO

Table I: Non-derivative

1 line
Date Transaction Shares Price Value Owned after D/I
2024-12-24 Sale : show line 1 in the form −8,400 $11.87 $99,708 263,150 D
Open-market sales · 8,400 sh · avg $11.87 · $99,708
Loading xslF345X05/ownership.xml…